Lars Hyman

Google's New Historical Document Search: Winners and Losers

ReedElsevier (RUK) income looks promising because
it increases extensive an reliable professional information to
doctors lawyers engineers, even prisondirectors.
This business segment has been doubled by the
purchase of the biggest US supplier.
Look for annual earnings of $ 4.-,increassing by 20-30
percent a year for at least the next 5 years.(BFGX-2008)
RUK's share price is currently $ 50.90

Jim Cramer's Mad Money In-Depth, 2/26/08: Feast in a Famine

Enjoy

Jim Cramer's Mad Money In-Depth, 2/26/08: Feast in a Famine

I am looking for the opinion of investors - gurus
on the changes at RUK, after buying the biggest
medical sciences supply company in the US.
RUK has doubled their great earnings in 2006
over 2007. Cost savings for the new company
will be some 25% while outlook earnings
comprises another double.....
RUK is a respected oldtimer..but
is going new places in 2008 and beyond...

Apple's A Short In Light Of Sales Data

I bought Apple at $ 20 - 3 years ago..
When it doubled, I sold.Obviously too soon
I bought again: now I will just
keep the stock until I can realize my dream:
retiring in Bermuda...

Lars